Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates

BACKGROUND: Coagulase negative staphylococci (CoNS) are the most common cause of neonatal sepsis in the Neonatal Intensive Care Unit (NICU). A minority of neonates does not respond to vancomycin therapy and develops persistent bacteremia, which may be treated with rifampin. We evaluated the use of r...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Lugt, N Margreth, Steggerda, Sylke J, Walther, Frans J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994847/
https://www.ncbi.nlm.nih.gov/pubmed/21092087
http://dx.doi.org/10.1186/1471-2431-10-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994847/
https://www.ncbi.nlm.nih.gov/pubmed/21092087
http://dx.doi.org/10.1186/1471-2431-10-84

Ejemplares similares